Physician profile
Brad Pfeffer
NPI 1255570842
$9,448.69
in general payments reported to CMS, 2019-2025
39 companies · $1,548 in 2025
The $1,548 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $870 · 2020: $284 · 2021: $641 · 2022: $2,109 · 2023: $2,247 · 2024: $1,750 · 2025: $1,548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,544.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,926.43 | 2019-2025 | Xience Skypoint, Dragonfly Opstar, Nc Trek Neo |
| Medtronic, INC. | $1,123.63 | 2022-2025 | Corevalve Evolut R, Micra, Symplicity G3 |
| Novartis Pharmaceuticals Corporation | $1,067.36 | 2019-2025 | |
| Edwards Lifesciences Corporation | $715.96 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $608.28 | 2019-2025 | Synergy, Avvigo Guidance System |
| Inari Medical, INC. | $430.71 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $385.10 | 2021-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $384.69 | 2021-2025 | Lifevest |
| Pfizer INC. | $237.63 | 2022-2025 | |
| Medtronic Vascular, INC. | $211.86 | 2019 | |
| Janssen Pharmaceuticals, INC | $193.40 | 2019-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $152.51 | 2023-2025 | Assure Wcd |
| Shockwave Medical, INC | $147.99 | 2022 | |
| Novo Nordisk INC | $144.40 | 2024-2025 | Wegovy, Ozempic |
| Esperion Therapeutics, INC. | $135.09 | 2021-2024 | Nexletol |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $134.11 | 2023-2025 | Amvuttra, Onpattro |
| Abiomed | $131.95 | 2022-2024 | Impella |
| Scpharmaceuticals INC. | $128.33 | 2024-2025 | |
| Amarin Pharma, INC. | $112.42 | 2020-2022 | |
| Stryker Corporation | $102.95 | 2025 | Flowtriever |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.36 | 2021-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $97.36 | 2022-2025 | Camzyos, Eliquis |
| Irhythm Technologies, INC. | $93.98 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $91.58 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Amgen INC. | $78.34 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $71.20 | 2022-2025 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $66.56 | 2024 | Arcalyst |
| Abbvie INC. | $61.72 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.92 | 2025 | |
| Chiesi USA, INC. | $53.52 | 2019-2021 | |
| Teleflex LLC | $41.87 | 2023 | Guideliner |
| Lantheus Medical Imaging, INC. | $39.04 | 2019 | |
| Cardiva Medical, INC. | $22.92 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Lexicon Pharmaceuticals, INC. | $21.27 | 2023 | Inpefa |
| Glaxosmithkline, LLC. | $17.43 | 2025 | Arexvy, Shingrix |
| Atricure, INC. | $16.10 | 2023 | |
| Terumo Medical Corporation | $15.78 | 2024 | Tr Band |
| Biotronik INC. | $14.48 | 2022 | |
| Cardinal Health 200 LLC | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Pfeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.